SeaStar Medical Holding (ICU) Earnings Analysis

SeaStar Medical Holding (ICU) next reports earnings on 2026-08-12, consensus EPS -0.97 USD. Last quarter (2026-03-25) it beat with EPS -0.8 USD vs -0.97 USD est (+17.5%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -0.95.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ICU next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.97 USD
Revenue estimate0.00B

ICU earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-25-0.8 USD-0.97 USD+17.5%Beat
2025-11-13-1.3 USD-1.5 USD+13.3%Beat
2025-08-13-0.18 USD-0.43 USD+58.1%Beat

Beat rate: 3/3 (100%) over reported quarters with consensus data.

ICU valuation and analyst view

Trailing P/E-0.95
Trailing EPS-0.30367 USD
Price / book20.84
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)
Avg price target8 USD

Related research pages

Frequently asked questions

When is SeaStar Medical Holding (ICU)'s next earnings date?

SeaStar Medical Holding is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.97 USD and revenue estimate of 0.00B.

Did ICU beat earnings last quarter?

In its 2026-03-25 report, ICU posted EPS of -0.8 USD versus a -0.97 USD estimate — a beat of 17.5%.

What is ICU's earnings track record?

Over the last 3 reported quarters with consensus data, ICU beat estimates 3 times (100%).

What is ICU's current P/E ratio and EPS?

ICU trades at a trailing P/E of -0.95 on trailing EPS of -0.3036745927292151 USD.

What do analysts rate ICU?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 8 USD.